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Edited by Horst FeldmannAbstract Aptamers are RNA or DNA oligonucleotides identi-
ﬁed within a randomly synthesized library, through an in vitro
selection procedure. The selected candidates display a pre-
determined property of interest with respect to a given target.
Successful selection has been carried out against targets ranging
from small (amino acids, antibiotics) to macro-molecules (pro-
teins, nucleic acids). They generally show an aﬃnity in the
nanomolar range and a high speciﬁcity of target recognition.
Interestingly, aptamers selected against puriﬁed targets in the
test tube retain their properties within cells. RNA aptamers can
be generated in situ from an appropriate DNA construct or
delivered as nuclease-resistant oligonucleotide analogues. For
example, aptamers recognizing RNA structure through loop–
loop interactions modulate the trans-activation of in vitro
transcription mediated by the TAR RNA element of human
immunodeﬁciency virus type 1. Consequently, they constitute
both exquisite tools for functional genomics analysis and
promising prototypes of therapeutic agents. Natural aptameric
motifs have been identiﬁed within mRNA sequences, which upon
binding to a metabolite control the expression of the encoded
gene, which is generally involved in the biosynthesis of this
particular metabolite.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Over the last 25 years a number of strategies have been
developed that make use of nucleic acids for artiﬁcially regu-
lating gene expression. The regulatory oligomers are designed
for generating speciﬁc complexes with a pre-determined target.
Consequently, the eﬀect is restricted to a single gene making
such oligonucleotides selective gene inhibitors. To this end
either nucleic acids or proteins can be targeted (Fig. 1). In the
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vents the reading of the encoded information [1]. Numerous
successful results have been reported both in vitro and in vivo
with antisense oligomers as well as with ribozymes which
cleave the target RNA at the hybridization site. Very recently
RNA interference opened new avenues for the inhibition of
translation in many organisms, through double-stranded RNA
generating so-called siRNA [2,3]. Triple-stranded structures
can be generated from a duplex DNA composed of one purine
strand and, consequently, one pyrimidine strand. This antigene
strategy has been demonstrated to eﬃciently prevent tran-
scription of various genes [4,5]. The binding of a protein (let us
say a transcription factor) to its target site can be competed out
upon supply of a decoy, an oligomer whose sequence is iden-
tical to the protein target site; this consequently prevents the
biological eﬀect of the factor on the downstream gene [6]. The
aforementioned strategies are rational ones: the regulatory
oligomer is designed according to established rules, e.g.,
Watson–Crick base pairing for antisense and siRNA. A
combinatorial approach termed Systematic Evolution of Li-
gands by EXponential enrichment (SELEX) described in 1990
oﬀers an alternative for the design of oligonucleotide ligands of
high aﬃnity, termed aptamers [7,8].
This strategy can be used against a wide variety of target
molecules leading to highly selective ligands of interest for
both therapeutic and diagnostic purposes. Iterative cycles of
selection and ampliﬁcation allowed the identiﬁcation of RNA
and DNA aptamers against proteins or nucleic acids. As far as
these targets mediate the control of the expression of a gene,
the cognate aptamers constitute speciﬁc artiﬁcial modulators
of biological processes, mimicking the behaviour of decoy or
antisense sequences. In contrast to rational strategies there is
no pre-requisite to the design of aptamers. Interestingly, gene
regulation can also be achieved through the association be-
tween RNA aptamers and small molecules, as exempliﬁed by
riboswitches. In this review, examples will be given of the
speciﬁc control of gene expression by aptamers targeted to
diﬀerent kind of targets. We will focus a large part of it on the
targetting of RNA structures.2. Kissing aptamers
Numerous RNA motifs play a key role in the transmission
of the genetic information. For instance, the trans-activating
responsive (TAR) element is a 59 nucleotide long imperfect
RNA hairpin located at the very 50-end of the humanblished by Elsevier B.V. All rights reserved.
Fig. 2. Sequence and secondary structure of loop–loop interacting
hairpins. (A) R06 is the RNA aptamer identiﬁed by in vitro selection
against TAR (the selected consensus sequence is in italic). TAR* is a
rationally designed TAR ligand. Bases susceptible to base-pair are in
bold. MiniTAR, a truncated version of TAR, has been used for kissing
complexes studies. (B) dsTAR is the double target model (see text), it
consists in the TAR BRU hairpin linked to TAR MAL by tri-ethylene
glycol phosphate units (thin line). BRU and MAL refer to two HIV-1
strains diﬀering by one base in the apical loop (the mutated base is
underlined). The double ligand, dR06, consists in two hairpin apta-
mers, R06MAL and R06BRU, complementary to their respective
target. These hairpins were linked by the same linker as the double
target. R06-DIS is the double ligand designed to recognize simulta-
neously the TAR and DIS hairpins within the 50-LTR of HIV-1 (see
text). (C) Mixmer LNA/DNA hairpin derivative of the R06 aptamer
recognizing TAR BRU. Capital and lower case letters represent LNA
and DNA bases, respectively.
Fig. 1. Strategies (listed to the right) for artiﬁcially regulating gene
expression by means of synthetic oligonucleotides. The speciﬁc binding
of an oligomer to DNA, pre-mRNA or mRNA in the nucleus (top), to
mRNA or to a protein (bottom) in the cytoplasm ultimately results in
the selective inhibition of protein function.
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trans-activator protein (Tat) binds speciﬁcally to a bulge in the
upper part of the TAR element and recruits the cellular cyclin
T1 and the associated kinase CDK9, at the apical loop of the
hairpin. This multi-protein–RNA complex hyperphosphory-
lates the carboxy terminal domain of the RNA polymerase II,
making this enzyme more processive [9,10]. Therefore, speciﬁc
ligands of the TAR RNA that would inhibit the binding of Tat
are expected to severely hinder the transcription of the HIV
genome and the development of the retrovirus. The TAR
RNA structure was used as a target for the in vitro selection of
aptamers.
2.1. R06 aptamer
In vitro selection against TAR identiﬁed RNA aptamers
recognizing the folded structure [11]. After ten selection rounds
the sequenced candidates revealed a consensus octamer,
50-GUCCCAGA-30, the six central bases of which were com-
plementary to the TAR RNA loop. Band shift assays were
performed between the radiolabelled target and these candi-
dates leading to a dissociation equilibrium constant of 20–50
nM under the selection conditions. Computer analysis used to
predict the secondary structure of these aptamers revealed that
they folded as imperfect hairpins. The 8-mer consensus se-
quence presented in the apical loop includes six bases com-
plementary to the TAR loop. A minimal binding motif could
be deﬁned for the aptamer of highest aﬃnity, R06, corre-
sponding to the top part of the 98-nt parent candidate. The
truncated aptamer, which retains similar TAR binding prop-
erties, is a perfect hairpin with a 8-bp stem and the octameric
sequence displayed in its apical loop (Fig. 2A). Enzymatic
footprints gave strong evidence for loop–loop interaction or
kissing-complex formation between TAR and R06. Further
analysis of the target-aptamer complex by band shift assay
demonstrated that Watson–Crick base pairing between the
loops was crucial for the stability of the bimolecular complex:
a point mutation in the R06 loop was detrimental for binding
to TAR. The aﬃnity for the target could be restored by in-troducing a compensatory mutation in the TAR loop. There-
fore, R06 can discriminate between two hairpins diﬀering by a
single base in the hexanucleotide loop.
However, complementarity between the loops did not fully
account for the binding capability of R06, suggesting that non-
canonical interactions between TAR and the aptamer were
crucial. Compared to the aptamer, the selected octameric se-
quence was a very poor ligand of TAR with an association
constant 2–3 orders of magnitude lower than the full-length
aptamer. Thermal denaturation experiments monitored by UV
spectroscopy revealed that the complex formed between TAR
and the 8-mer consensus sequence was characterized by a
melting temperature (Tm) lowered by 27 C compared to that
of the full-length aptamer–TAR complex [12]. Binding to im-
mobilized TAR, monitored by surface plasmon resonance
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was injected over the sensorchip surface, while at a similar
concentration the hairpin aptamer gave rise to clear associa-
tion and dissociation phases [12]. Therefore, even if the loop–
loop interaction was driven primarily by Watson–Crick base
pairing, stability of the complex required the interacting region
to be presented in a structured context.
The structure of the kissing complex formed by TAR and
TAR* (Fig. 2A), a rationally designed hairpin with a six-nu-
cleotide loop complementary to the TAR loop and a 5-bp
stem, was shown by NMR spectroscopy to be bent towards the
major groove of the loop–loop helix with an angle of 30 [13].
A quasi-continuous stacking of base pairs from one stem helix
to the other one, through the loop–loop helix was observed.
These structural features were also observed in other kissing
complexes derived from NMR experiments [14–16]. In con-
trast an almost straight coaxial stacking of the helices was
observed in the crystal structure of the 23S RNA kissing
complex [17] and in the DIS–DIS one [18], a kissing complex
that constitutes the initial step of the dimerization process of
the human immunodeﬁciency virus type 1 (HIV-1) genome.
Interestingly, molecular dynamics (MD) performed on the
TAR–TAR* solution structure reconciled these observations
[19]. The initial curvature of the structure disappeared during
the ﬁrst nanosecond of the simulation run and TAR–TAR*
adopted an almost straight coaxial structure, indicating that
this latter conformation was likely the most stable one. The
three-dimensional structure of TAR–R06 is not known yet but
one can reasonably expect that this complex adopts an overall
conformation similar to that observed for other RNA–RNA
loop–loop complexes. In particular, TAR–R06 as other kissing
complexes was recognized by the structure speciﬁc Rop protein
encoded by the ColE1 plasmid from Escherichia coli [20].
The 8 nt loop of the anti-TAR R06 aptamer corresponding
to the selected consensus shows selected G and A residues
ﬂanking the six nucleotide sequence complementary to the
TAR loop [11], suggesting that they might play a role for the
stability of the TAR–aptamer complex. This was demonstrated
by investigating the properties of diﬀerent combinations of
loop closing residues [11,12]. Purine,purine combinations gave
rise to the less destabilized TAR–aptamer complexes, the A,G
combination, for instance, being almost equivalent to the se-
lected G,A one. In contrast, pyrimidine, pyrimidine combi-
nations drastically decreased the stability of the complex. It is
worth noting that complex stability was not directly related to
the aptamer stem stability. The G,C combination, for instance,
that provided the aptamer stem with an additional Watson–
Crick base pair, generated an aptamer of increased thermal
stability compared to the selected aptamer (DTm ¼ þ11 C)
but the resulting bimolecular complex with the viral target was
less stable (DTm ¼ 16 C). The U,A combination that gave
rise to a TAR*-like aptamer resulted in a )17 C decreased
thermal stability of the complex that exactly matched the
stability obtained with TAR*, suggesting that the increased
stability of the TAR–R06 complex over TAR–TAR* really
originated in the G and A residues closing the aptamer loop.
This result validated the usefulness of an in vitro combinato-
rial approach over a rational one to identify high aﬃnity RNA
ligands.
Kinetic analysis by SPR further emphasized the stabilizing
role of the G and A residues [12]; the decreased stability of the
complexes formed with the mutated aptamers originated in afaster dissociation reaction, while the association reaction re-
mained unchanged. In the selection buﬀer which contained 3
mM Mg2þ, binding of TAR* to TAR was hardly detected.
Structural studies have suggested that the stabilizing eﬀect of
this cation on loop–loop complexes would result from direct
binding in two speciﬁc metal ion binding sites made by phos-
phate clusters ﬂanking the major groove of the loop–loop helix
[13,14,21].
MD was used recently to investigate the role of the residues
closing the aptamer loop [19]. As the three-dimensional
structure of TAR–R06 is not established yet, the TAR–TAR*
solution structure was taken as the starting structure. The
TAR* hairpin was converted into an R06 like aptamer by
substituting the U closing the loop on the 50-side by a G, thus
generating the characteristic loop closing G,A combination.
The choice of the initial conformation of these residues was
obviously crucial. The MD results on TAR–TAR* showed
that the UA base pair next to the TAR* loop adopted a
conformation characterized by a large C10–C10 interglycosidic
distance, which likely favoured stacking of the bases at the
stem–loop junctions. Taking also into account the preliminary
NMR experiments on TAR–R06, which suggested that the GA
base pair did not adopt a sheared conformation, the G,A bases
were positioned in a cis Watson–Crick/Watson–Crick confor-
mation. The results obtained during the MD simulation runs
suggested that the stabilizing role of G,A likely resulted from
inter-backbone hydrogen bonds that were not observed in the
TAR–TAR* structure and an optimized stacking of the bases
at the stem–loop junctions.
Stacking interactions as key structural determinants for
stable kissing complexes were also demonstrated in the case of
a loop–loop interaction derived from a transient RNA–RNA
kissing complex that regulates the replication of the E. coli
plasmid ColE1, by introducing 2-aminopurine ﬂuorescent
probe, an analogue that forms with uracil a Watson–Crick
base pair isosteric with AU at the stem–loop junctions [22].
Kinetic analysis of the interaction by ﬂuorescence-detected
stopped-ﬂow experiments showed that loop–loop association
followed a two-step mechanism: an initial encounter reaction
was followed by a slower kinetic step that might reﬂect an
isomerization reaction for optimizing the stacking interactions
at the stem–loop junctions.
Other in vitro selection of RNA candidates against RNA
hairpins further supported the idea that purine-purine base
pairs might be preferred for closing hairpin loops involved in
RNA loop–loop interactions. Scarabino et al. identiﬁed hair-
pin aptamers that bound to the anticodon loop of the yeast
tRNAphe through kissing complex formation [23]. As reported
for the R06 anti-TAR aptamer, the 7 nt loop of the aptamer
complementary to the anticodon loop was ﬂanked by G and A
residues. In vitro selection against the DIS hairpin that regu-
lates dimerization of the HIV-1 RNA genome also selected
kissing aptamers showing mostly purine-purine combinations
to close the loop [24]. However, the A,A combination was
preferred over all others, including GA, conﬁrming that the
identiﬁed AA sheared pair that ﬂanked the auto-complemen-
tary hexanucleotide sequence was crucial for dimerization [25].
In vitro selection of DNA candidates against TAR RNA led
also to aptamers that formed loop–loop complexes with the
viral target. However, footprinting studies [26] and NMR ex-
periments [27] showed that the conformation of the RNA–
DNA interacting loops diﬀered from that of the TAR–RNA
Fig. 3. Schematic representation of the sugar conformation adopted by
DNA, RNA, 20-OMe, NP-DNA and LNA monomers.
58 J.-J. Toulme et al. / FEBS Letters 567 (2004) 55–62aptamer complex. The loop–loop interaction involved only ﬁve
base pairs instead of six for TAR–R06. In contrast to this
latter complex that has no linking residue to connect the loop–
loop helix to the TAR or aptamer stems, one RNA and two
DNA residues constituted linkers in the TAR–DNA aptamer
complex. Diﬀerence in geometry between RNA–RNA and
DNA–RNA loop–loop complexes was further supported by
the fact that the TAR–DNA aptamer was not recognized by
the Rop protein. The RNA–DNA loop–loop helix was even
diﬀerent from that of linear RNA–DNA duplexes as it was not
recognized by the E. coli RNase H protein. These results in-
dicate that depending on the chemistry of the random pool, the
selection process evolved not only to optimize the Watson–
Crick interactions that primarily drive loop–loop interactions
but also to favour non-canonical interactions that signiﬁcantly
contribute to the thermodynamic stability of kissing
complexes.
2.2. Chemically modiﬁed aptamers
In vitro selected DNA or RNA aptamers are ligands that
display high aﬃnity and strong selectivity for their target and
might be of interest for biological applications such as the
regulation of gene expression. When used in a cellular context,
eﬃciency of the selected candidates decreased inevitably as
their life-time is drastically reduced by nuclease degradation.
Several modiﬁcations were developed in the frame of the an-
tisense strategy to circumvert this limitation and even to im-
prove the aﬃnity for the targeted sequences [28]. Two
approaches can be used to generate nuclease-resistant apta-
mers. The ﬁrst one takes advantage of some unnatural nucle-
otides that can be enzymatically incorporated by the
polymerases during the selection process. Phosphorothioate
linkage in place of phosphodiester is compatible with the SE-
LEX enzymes [29]. 20-Fluoro and 20-amino pyrimidines are
chemically modiﬁed nucleotides that were successfully used to
generate nuclease resistant aptamers [30,31].
The second approach which consists in introducing post-
selection, chemical modiﬁcations in the selected aptamer is
risky. The chemistry of the random pool dictates the structure
of the complex, reﬂecting the exquisite adaptation of the apt-
amer to its target. A DNA version of the R06 RNA aptamer is
a poor TAR ligand and vice versa. Then, any modiﬁcation that
will alter the geometry of the nucleotides could aﬀect aﬃnity
and speciﬁcity of the selected candidates for the target. In this
context, modiﬁcations that will retain the conformation of the
parent aptamers will generate a priori good mimics. 20-O-me-
thyl (20-OMe), N30 !P50 phosphoramidate deoxynucleotide
(NP-DNA) and ‘‘locked nucleic acid’’ (LNA) (Fig. 3) modiﬁ-
cations confer resistance to nucleases and adopt the N-type
(C30-endo) conformation characteristic of the RNA [32].
Indeed, fully modiﬁed 20-OMe and NP-DNA R06 deriva-
tives formed complexes with TAR, characterized by similar or
even slightly higher aﬃnity constants than the parent RNA–
RNA complex [33,34]. Moreover, these derivatives retained
the key structural determinants identiﬁed by in vitro selection.
In particular, the crucial G,A loop-closing combination of the
aptamer still contributed to the thermodynamic stability of the
complex indicating that they adopted an overall conformation
close to that of the selected TAR–RNA complex. However,
these chemical modiﬁcations introduced subtle changes in the
geometry of the resulting kissing complex and the loop–loop
helices diﬀered from that observed with linear hybrids. Incontrast to the RNA–RNA kissing complex, neither 20-OMe-
nor NP-DNA–TAR complexes were recognized by the Rop
protein. Moreover, the increased stability per modiﬁed residue
of 20-OMe-RNA (DTm ¼ þ0:5 C) [35] or NP-DNA–RNA
(DTm ¼ þ2:5 C) [36] versus RNA–RNA linear duplexes was
not observed. This further underlined the non-canonical con-
formation of the loop–loop region.
The results obtained with LNA analogues illustrate that
post-selection modiﬁcation of aptamers is not trivial and that
C30 endo-conformation of the incorporated modiﬁed nucleo-
tides will not always guarantee success. LNA is a recently in-
troduced chemical modiﬁcation that generates the most stable
hybrids ever characterized with a DTm of þ3 C and þ10 C
per LNA residue upon binding to DNA and RNA, respec-
tively [37]. In contrast to fully 20-OMe and NP-DNA versions
of R06, the LNA aptamer did not form a stable complex with
TAR. Neither were good ligands hairpins that displayed an
LNA stem with a DNA loop or vice versa (Darfeuille et al.,
unpublished).
Having in mind that ﬂexibility of the ribose ring was re-
stricted due to the 20-O,40-C-methylene linkage and that olig-
omers which alternated DNA and LNA nucleotides adopted
an overall A-type conformation [37–39], a series of mixmer
LNA/DNA hairpins were synthetized. No rules really dictated
the positions at which DNA or LNA residues were introduced.
One derivative, LNA06, (Fig. 2C) with the G and A residues
closing the loop being DNA, led to a complex as stable as the
one obtained with the parent RNA aptamer. As previously
observed with 20-OMe and NP-DNA modiﬁed aptamers, the
LNA modiﬁcation did not generate a complex of increased
stability. Further analysis of the interaction between the mix-
mer DNA/LNA derivative and the viral target showed that
stacking interactions at the stem–loop junctions were still
crucial and related to the identity (G and A) and the chemistry
(DNA) of the nucleotides closing the loop of the hairpin an-
alogue. Surprisingly, the LNA/DNA antisense octamer (cor-
responding to the hairpin loop) displayed the same aﬃnity for
the target as the aptamer, even if it behaved kinetically dif-
ferently, whereas its RNA version hardly bound to TAR
RNA. However, kissing over antisense interactions provided
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of in vitro selection (Darfeuille et al., unpublished).
The biological eﬀect of 20-OMe and NP-DNA anti-TAR
aptamer derivatives was evaluated. Both analogues were in-
hibitors of the Tat-mediated in vitro transcription with an IC50
of about 400 nM compared to >4 lM for the in vitro selected
RNA aptamer [33,34]. This eﬀect was speciﬁc as the R06 an-
alogue with a loop-closing C,U combination, which did not
bind to TAR, did not inhibit Tat-mediated transcription. As
demonstrated with the NP-DNA hairpin and a Tat peptide,
the inhibitory eﬀect was likely in part related to a competition
between the viral protein and the chemically modiﬁed aptamer
for binding to TAR. Interestingly, as the binding sites of these
ligands do not overlap this suggested that interaction of the
aptamer analogue induced structural changes that prevent Tat
binding or inhibited the conformation changes of the TAR
RNA taking place upon Tat binding.3. From mono- to bi-functional aptamers
Aptamers can be used to ﬁnely tune gene regulation by in-
teracting with regulatory RNAs through loop–loop interac-
tions (see above). Examples of natural RNA regulators
working through similar types of complexes have been de-
scribed in prokaryotes [40]. Most of these natural regulators
consist in several structural motifs and engage several inter-
actions simultaneously. One could take advantage of such an
organization to rationally design RNA aptamers that could
interact with their target at multiple binding sites. Compared
to strategies that target one individual structural motif, this
approach is expected to increase both the stability and the
speciﬁcity of the resulting complexes.
3.1. Double loop–loop complexes
In order to validate multivalent structured RNA aptamers
as ligands of increased aﬃnity and speciﬁcity for highly
structured RNA targets, a model of interaction consisting in a
double kissing complex was ﬁrst developed on the basis of the
previously described TAR–R06 complex. Two variants of the
TAR RNA element – namely BRU and MAL – are known
which essentially diﬀer by a single base in the loop. The double
target consisted in truncated versions of BRU (TAR BRU)
and MAL (TAR MAL) TAR RNA hairpins, connected to
each other by three tri-ethylene glycol phosphate (C9PEG)
units to generate dsTAR (Fig. 2B). The bivalent ligand was
derived from a shortened version of the RNA aptamer R06
(R06BRU) that had been raised against TAR BRU (Fig. 2B).
An aptamer selective for the TAR MAL hairpin (R06MAL)
was merely generated from R06BRU by introducing an A!G
compensatory mutation in the aptamer loop. This aptamer,
R06MAL, was shown to bind its target through a loop–loop
interaction, as well [33,34]. The stems of these two hairpins
have been shortened down to ﬁve base pairs and linked to each
other by the same C9PEG linker as the double target thus
giving rise to dR06. Moreover, mutants of the double ligand
have been produced by substituting the three Cs in the loop by
three As given that this mutation drastically decreases the
stability of the BRU and MAL complexes.
Under 1 mM Mg2þ, the R06BRU/dsTAR and the
R06MAL/dsTAR complexes displayed Kd values equal to 6.2
and 1.0 nM, respectively, as measured by band-shift assays.The dissociation equilibrium constant for the dR06/dsTAR
complex could not be determined since at the ﬁrst concentra-
tion used, 0.4 nM, 90% of the radiolabelled ligand was shifted.
The enthalpy of formation, DH , of each complex was deduced
from the variation of the melting temperature monitored by
UV absorption spectroscopy in function of the total RNA
concentration. Under 0.1 mM Mg2þ, dR06, R06BRU and
R06MAL, respectively, displayed DH values of )407.4, )63.3
and )66.1 kcal mol1 (Boucard et al., unpublished). These
results demonstrated that multiple structured interactions can
generate complexes of increased stability compared to the
parent individual complexes. In addition, the link between
the two hairpins gave rise to a cooperative interaction since the
enthalpy of the double complex was three times the sum of the
two individual ones. This could be explained by a structural
rearrangement once the two sites of the double aptamer are
bound to their respective target. This hypothesis was sup-
ported by the fact that, on a native polyacrylamide gel, the
dR06/dsTAR complex migrated much faster than the complex
formed by the two single ligands mixed together and dsTAR.
Hence, the increased stability of the double kissing complex
over the single ones would stem not only from an increased
number of base pairs but also from a peculiar conformation
that would be thermodynamically favourable.
SPR experiments carried out under 1 mMMg2þ have shown
no signiﬁcant diﬀerences between the association rates (Bou-
card et al., unpublished). The on-rates observed for mono- and
bi-functional complexes were actually in the same range of
values. In contrast, the dissociation rate of the double kissing
complex (koff ¼ 3:8105 s1) was about one order of magni-
tude lower than the ones observed for the monovalent com-
plexes. The study of this model has thus shed light upon the
advantages of using multifaceted structural interactions to
target highly organized RNA elements.
3.2. Simultaneous targetting of RNA hairpins in the HIV-1
genome
This bi-modal interaction strategy has then been applied to
the design of bivalent RNA ligands capable of recognizing the
50-untranslated region (50-UTR) of the HIV-1 genome by
multiple interactions. This region is actually highly structured
and is composed of several hairpins that constitute regulatory
elements for diﬀerent steps of the viral cycle, making these
structural motifs valuable targets for our strategy [41]. The
Dimerization Initiation Site (DIS) has been shown to trigger
the retroviral RNA dimerization through the formation of a
kissing complex between two DIS elements which contain a
palindromic sequence in the hairpin loop [42,43]. We generated
a double hairpin aptamer by linking a DIS hairpin to R06BRU
through a hexa-ethylene glycol phosphate unit. Band shift
assays have been performed to determine the apparent disso-
ciation constants, Kd, of the radiolabelled single or double li-
gands upon the 50-UTR. The apparent binding constant for
DIS/50-UTR is higher than 200 nM as no complex was de-
tected with the DIS hairpin alone in the concentration range
used for these experiments. The Kd values obtained for the
R06/50-UTR complex suggested that this aptamer only inter-
acted with the TAR hairpin with a Kd of 3.6 nM, in fair
agreement with previous results. The double aptamer, R06-
DIS, could also dimerize through its DIS element but this in-
teraction did not prevent the binding of this ligand to the
50-UTR. The bifunctional aptamer ligand displayed a
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R06 alone (Kd < 0:4 nM). This would suggest that both sites
of the bivalent ligand simultaneously interacted with the
50-UTR thus leading to a very stable complex (Boucard et al.,
unpublished).
The inhibitory eﬀect of these ligands was tested in an in vitro
reverse transcription assay. No signiﬁcant eﬀect was observed
with either the DIS hairpin or with the R06 aptamer. In con-
trast, R06-DIS displayed a speciﬁc inhibitory eﬀect with an
IC50 of about 100 nM. These results clearly demonstrated the
correlation between the aﬃnity and the inhibitory eﬀect of the
aptamers. Several aptamers directed against the reverse
transcriptase had been previously demonstrated to be good
inhibitors of the HIV-1 reverse transcription in vitro or in
cultured cells [44–46]. The ‘‘bifunctional aptamer’’ strategy
therefore extends the repertoire of potential targets for the
design of antiviral molecules.
This work proved that one can design aptamers that could
interact with their targets by multiple binding sites by com-
bining previously identiﬁed individual aptamers. However, one
should take care of the correct folding of such aptamers in
order that each domain within the complex behaves as the
isolated element. This could be achieved by re-inforcing the
stem regions in order to prevent intramolecules rearrangement
as previously achieved, for instance, for aptamers targeted to
the drosophila B52 protein [47].
3.3. Aptamers targeting proteins
Proteins are the most frequently used targets for the devel-
opment of aptamers. RNA and DNA ligands have been
identiﬁed for nuclear, cytoplasmic and membrane proteins
[48,49]. As speciﬁc binders, aptamers are potential inhibitors of
protein function. This might result either from an interaction
at the catalytic site of an enzyme or from a competition with
the natural ligand, let us say a DNA or an RNA sequence.
A number of examples are available in the ﬁeld of viruses
(HIV, HTLV, HCV). An RNA aptamer 37 nt long was iden-
tiﬁed against the protein Tat of HIV-1 [50]. The binding con-
stant of this aptamer for Tat was two orders of magnitude
higher than that of the natural TAR element making it a very
eﬃcient competitor for the authentic RNA site. Interestingly,
this aptamer, composed of two inverted repeats of a TAR-like
motif, is a selective inhibitor of the Tat-dependent trans-acti-
vation of transcription [51]. As it does not contain the apical
loop of the retroviral TAR element, this aptamer does not trap
cellular proteins. Consequently, it shows eﬀects restricted to
TAR mediated transcription and does not interfere with cel-
lular processes involving the host protein cyclin T1 and CDK9.
Other regulatory retroviral proteins have been successfully
targeted such as the Rex protein of HTLV-1 [52] or the Rev
protein of HIV-1 [53] that modulate the early phases of the
viral life cycle through the transport of incompletely spliced
RNA to the cytoplasm.
Applying the SELEX procedure to the HIV-1 reverse
transcriptase led Tuerk et al. [54] to the identiﬁcation of an
RNA pseudo-knot which displayed both an extremely high
binding constant (Kd  25 pM) and a strong inhibitory eﬀect.
The interest of this aptamer was later on evaluated in cultured
cells. The expression of this aptamer, within a chimeric gene,
was driven by a Pol III promoter in order to ensure an ap-
propriate cytoplasmic localization. In stably transfected T-
lymphoid cells, the pseudo-knot construct speciﬁcally reducedthe replication capability of the virus [46]. In another study it
was demonstrated that this pseudo-knot aptamer was also a
potent reverse transcriptase inhibitor in bacterial cells [44].
Therefore, aptamers selected in vitro against a puriﬁed protein
retain their binding eﬃcacy on endogenous target and may
modulate their biological function. Furthermore, no toxic ef-
fect of intracellular aptamers was reported. The main limita-
tions is their delivery. This is less problematic when the target
is localized outside the cell. 20-Fluoro-pyrimidine containing
aptamers were isolated, against the HIV-1 surface protein
gp120 which mediates the interaction with host-cell receptors.
These high aﬃnity ligands (Kd¼ 5–100 nM) neutralize HIV-1
infectivity in human peripheral blood mononuclear cells [55].
Moreover, these aptamers were also demonstrated to neu-
tralize clinical isolates of HIV-1.
The use of aptamers is not restricted to the inhibition of viral
proteins. Speciﬁc control of gene expression has also been
achieved with aptamers targeted to transcription factors. RNA
aptamers raised against NF-jB recognized its target in yeast.
Interestingly, the in vitro selected aptamers were further op-
timized through yeast genetic selection, the combination of in
vitro and in vivo processes providing ligands with decoy
properties [56].
3.4. Regulation of gene expression through riboswitches
Aptamers have been converted into switches for turning on
and oﬀ the expression of a downstream gene. This is illustrated
by the work of Werstuck and Green who selected aptamers to
small molecules (antibiotics or Hoechst dyes) and inserted
these aptamers into the 50-UTR of a reporter gene [57]. The
binding of the drug stabilizes the aptamer structure and pre-
vents the scanning of the 50 leader region or the binding of the
ribosome to the mRNA. Consequently, the translation of the
reporter gene was repressed both in an in vitro assay and in
cultured CHO cells upon the administration of the drug. The
eﬀect was shown to be speciﬁc and induced exclusively by the
relevant drug: a related molecule did not show any inhibitory
eﬀect. Other examples of similar conditional expression have
been described in yeast: the insertion of tetracycline-aptamer
near the start codon reduces the expression of the downstream
GFP gene [58].
Interestingly, in the last few years several examples of reg-
ulatory processes were described that make use of ‘‘natural
aptamers’’. These switches are mediated by an RNA structure
which constitutes a highly selective binding site for a metab-
olite. Upon association between the metabolite and the
mRNA, the structure element undergoes a conformational
change that leads to the alteration in the expression of this
gene. As the regulated gene is directly related to the production
of the metabolite, these sensors oﬀer a direct link between the
biochemical surrounding and the genetic information.
The regulation of thiamine genes, a co-factor of key enzymes
in carbohydrate metabolism, is negatively controlled by thia-
mine and thiamine pyrophosphate. An evolutionary conserved
element – the thi box – has been identiﬁed in the 50-untrans-
lated region of those thi genes. It was demonstrated that 50
leaders of E. coli thiC and thiM mRNAs bind directly to thi-
amine pyrophosphate. The association of the metabolite in-
duces a conformational change correlated to the control of the
operon function. This response is highly speciﬁc as several
thiamine analogues do not trigger the switch [59]. Other RNA
elements have been identiﬁed which respond to other metab-
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[60]. The FMN sensor binds riboﬂavin about 3 orders of
magnitude less tightly than the mononucleotide which diﬀers
by only one phosphate group [59]. Therefore, the RNA apt-
amer motif managed for producing stabilizing interactions
between anionic species, likely through the involvement of
metal ions.
Remarkably, these metabolite-binding elements are found
in the genome of numerous prokaryotic species but also in
eukaryotes. The thiamine pyrophosphate (TPP) domain was
identiﬁed in fungi and in plants, and was shown to bind TPP,
suggesting that riboswitches might also control gene expres-
sion in higher organisms [61]. However, the mechanism by
which the sensor mediates the regulation can be diﬀerent. In
E. coli the TPP-induced alteration sequesters the Shine and
Dalgarno sequence in the complex, thus preventing transla-
tion. In Bacillus subtilis, the TPP-dependent structural change
generates a terminator hairpin thus inducing transcription
termination. In Arabidopsis thaliana the TPP binding domain
is located in the 30-UTR, whereas in Neurospora crassa it lies
in an intron suggesting that in these organisms gene regula-
tion might occur at the processing stability and splicing lev-
els, respectively [61]. Therefore, the signal (the riboswitch) is
not part of the function (the gene regulation) a situation
reminiscent to what was previously described for the iron
responsive element (IRE). This RNA imperfect hairpin con-
trols the expression of genes involved in the metabolism of
iron through the speciﬁc association with IRE-binding pro-
teins. Located either in the 50- or in the 30-untranslated re-
gion, the IRE element acts at the translational or at the
RNA stability level of the ferritin and transferrin messages,
respectively [62].4. Conclusion
Aptamers have been shown to be ligands of both strong
aﬃnity and high speciﬁcity. Kds in the low nanomolar range
are frequently observed. Examples are available of RNA ap-
tamers that discriminate between molecules diﬀering by a
single methyl or a phosphate group. This review summarizes
examples showing the potential of aptamers as gene regulators.
Both riboswitches and artiﬁcial aptamers are functional in vivo
demonstrating the biological interest of RNA scaﬀolds as
‘‘sensor’’ elements. The potential interest of aptamers has also
been demonstrated in the ﬁeld of diagnostics. Phase III clinical
trial is underway for an aptamer targeted to VEGF in the case
of wet macular degeneration.
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